The Centers for Disease Control and Prevention claimed that fully vaccinated persons are at a higher risk of COVID-19 infection with the Delta variant and can spread the disease as easily as those who have not been vaccinated.
Research recently calculated the risk of a vaccine-resistant COVID-19 strain that's emerging under different scenarios, a modified model of the virus's transmission showed.
Even after being fully vaccinated with mRNA vaccines, which are regarded to be the most effective, transplant patients cannot generate antibodies against the coronavirus.
A recent study published in The New England Journal of Medicine confirms that the Pfizer vaccine works effectively against the COVID-19 delta variant, with a whopping 88% efficacy.
COVID-19 vaccines are shown to be strongly effective in preempting symptomatic, clinically apparent disease, and most specifically the rise of the COVID-19 Delta variant.
New research recently demonstrated the possible efficacy of an inhalable COVID-19 vaccine, one of the many vaccines in development designed to be given through a nasal spray.
Recent updates report 50 states, including Washington DC, are already infected with the COVID-19 delta variant. Experts recommend that people get vaccinated for protection against the virus.
Phase 1 of the randomized clinical trials regarding the edible rice vaccine against cholera had been a success. Further trials are expected for the cholera vaccines to be produced to combat the deadly cholera bacteria.
Researchers recently developed a technology for COVID-19, something that will enable them to study the virus, particularly its evolution inside the test tube.
Brazilian city Serrana residents have regained hope after researchers recently vaccinated nearly its whole adult population via the "Project S" in a city-wide vaccination experiment this spring.
University of Pennsylvania researchers made a drug known as diABZI, showed potent activity against the SARS-CoV-2, including the South African variant B.1.351, a Variant of Concern.